EyePoint Pharmaceuticals News

EyePoint Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.69%)

01:00

EyePoint Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.8%)

Oct 23 03:32

EyePoint Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Hassan Fred

Sep 6 04:08

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hassan Fred

Sep 6 04:08

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DICICCO WENDY F

Aug 22 04:36

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director ANDO GORAN

Aug 22 04:06

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Zaderej Karen L.

Aug 22 04:05

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lurker Nancy

Aug 21 04:09

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lurker Nancy

Jul 27 04:49

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GUYER DAVID R

Jul 17 04:28

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Duker Jay S.

Jul 13 05:08

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lurker Nancy

Jul 13 05:07

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Zaderej Karen L.

Jul 13 05:04

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director ADAMIS ANTHONY P

Jun 26 04:23

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GUYER DAVID R

Jun 5 04:35

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Elston George

May 29 10:38

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GUYER DAVID R

May 17 05:23

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Cormorant Asset Management, LP

May 9 05:03

EyePoint Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Management, L.P.(9.90%),Robert Atchinson(9.90%), etc.

May 2 05:12

EyePoint Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adage Capital Management, L.P.(10.35%),Robert Atchinson(10.35%), etc.

May 1 08:57